Withania somnifera

DIETARY_SUPPLEMENT3 trials

Sponsors

Sunnybrook Health Sciences Centre, Ivan Luzardo-Ocampo, Medical University of Lodz

Conditions

ALSDepression SymptomsObesityOverweightPolycystic Ovarian Syndrome (PCOS)Polyendocrine Metabolic Ovarian SyndromeStress

Phase 2

NF-κB Inhibition in Amyotrophic Lateral Sclerosis

Sunnybrook Health Sciences CentreALS

Start: 2021-10-19End: 2022-09-30Target: 75Updated: 2022-06-06

Unknown Phase

Impact of Ashwagandha in Obesity Parameters from Mexican Adults

CompletedNCT06676605

Ivan Luzardo-OcampoObesity, Overweight

Start: 2023-01-10End: 2024-01-30Updated: 2024-11-06

The Effect of Standardized Withania Somnifera Extract on Endocrine, Metabolic, and Psychometric Parameters, in Women With Polyendocrine Metabolic Ovarian Syndrome

CompletedNCT07750899

Medical University of LodzDepression Symptoms, Polycystic Ovarian Syndrome (PCOS), Polyendocrine Metabolic Ovarian Syndrome +1

Start: 2025-01-16End: 2026-05-29Updated: 2026-08-06